Table A1.
Reference | Effective Dose | Pregnant Mothers | Offspring Childhood | Offspring Adulthood | ||
---|---|---|---|---|---|---|
Male | Female | Male | Female | |||
[51] | 2.5 µg/kg/day | No effect on lipid metabolism | NS foetus hepatic TG and TC content | |||
[43] | 1 and 100 µg/kg/day | Week 14 | ||||
↑ hepatic TG (1 and 1000 BPA) ↑ liver weight (1 BPA) |
↑ hepatic TG (1000 BPA) ↑ liver weight (1000 BPA) |
|||||
[43] | 1 µg/kg/day | Week 14 | ||||
↑ hepatic TG ↑ glucagon ↑ fasting glucose ↑ insulin levels ↑ IPGTT ↑ IPITT |
NS hepatic TG NS glucagon NS fasting glucose NS insulin levels NS IPGTT NS IPITT |
|||||
[44] | 5 μg/kg/day | 4 weeks | 10 and 21 weeks | |||
↓ BW | NS BW | ↑ glucose clearance ↑ plasma ↑ TG ↑ FFA ↑ UC ↑ VLDL ↑ hepatic TC content NS TC NS HDL NS LDL |
↑ BW (13, 14, 20, and 22 weeks) ↓ hepatic TG NS lipid parameters NS insulin NS glucose tolerance |
|||
[52] | 100 μg/kg/day | NS BW | NS birth weight ↑ hepatic TG ↑ FFA NS body composition (fat/lean mass ratio) |
↑ BW but NS ↑ energy intake but NS ↑ body composition (fat/lean mass ratio) |
||
[55] | 2.5 µg/Kg/day | ↓ BW third week | ↑ birth weight | |||
[45] | 0.5 or 50 µg/Kg/day | 5 and 52 weeks | ||||
↑ insulin secretion (0.5 BPA) ↓ insulin secretion (50 BPA) | ||||||
[56] | 0.5 and 5 mg /Kg/day | 21 Months | ||||
NS plasma triglyceride (0.5 and 5 mg/Kg/day) ↑ hepatic and muscular TG content (0.5 and 5 mg/Kg/day) ↓ plasma LMW adiponectin levels (5 mg/Kg/day) | ||||||
[57] | 10 μg/kg/day and 10 mg/kg/day |
↓ Birth weight ↓ BW (PND 14 and PND 21) |
NS birth weight | PND 98 to PND 117 | ||
↑ BW and body fat content (PND 98 and PND 117)↑ insulin levels (10 μg/kg/day) NS fasting glucose level in both doses ↑ IPGTT (10 mg/kg/day) ↓ maximal glucose stimulated insulin release |
NS fasting glucose level NS IPGTT |
|||||
[53] | 50 µg/ kg/day | ↓ gWAT at PND 45 glucose intolerance at PND 35 |
↑ BW PND 70-170 NS food intake IR at PND 125 |
|||
[54] | 0.5 or 50 µg/kg/day | NS BW NS water and food intake |
5 Weeks | |||
↑ plasma TG (0.5 µg/kg/day) | ↑ plasma TG (50 µg/kg/day) | |||||
52 Weeks | ||||||
↓ BW (0.5 µg/kg/day) IR (0.5 µg/kg/day) NS plasma TG NS cholesterol NS leptin NS adiponectin |
↑ BW (50 µg/kg/day) NS plasma TG NS cholesterol NS leptin NS adiponectin |
|||||
[47] | 10 μg/kg/day | ↑ hepatic TG levels at PND 196 ↑ BW at PND 196 ↑ insulin level at 28 weeks ↑ perigonadal fat pad weight at 28 weeks ↑ fasting blood glucose at 17 weeks but NS impaired glucose tolerance |
||||
[48] | 1 and 10 µg/mL | NS BW NS food and water intake |
↑ BW both doses (PND 7-100) ↑ Blood glucose ↑ insulin ↓ serum adiponectin at (10 µg/mL BPA) PND 50 |
↑ BW both doses (PND 7-100) ↑ blood glucose ↑ insulin ↓ serum adiponectin IR at (1 and 10 µg/mL BPA) PND 100 |
||
[58] | 50 μg/kg/day | 3 weeks NS BW NS blood glucose ↑ serum insulin 21 weeks ↑ BW ↑ insulin resistance impaired glucose tolerance in rats’ hepatic tissue |
||||
[26] | 1 or 20 µg/kg diet BPA |
Both low doses NS BW NS food intake |
NS BW Impaired glucose tolerance ↑ plasma insulin NS leptin level |
NS BW NS glucose tolerance ↑ plasma leptin |
||
[59] | 10 or 100 µg/kg/day | Glucose intolerance (10 µg/kg/day) ↑ insulin sensitivity ↑ leptin ↑ TG ↑ glycerol (100 µg/kg/day) |
3 months NS insulin resistance NS glucose intolerance 6 months ↓ glucose tolerance ↑ insulin resistance ↓ BW (10 µg/kg/day) ↑ leptin (100 µg/kg/day) |
3 months NS insulin resistance NS glucose intolerance |
||
[49] | 25 mg BPA/kg diet | Did not alter the expression of insulin or increase in glucagon expression in BPA-exposed foetal pancreatic islets | ||||
[60] | 100 µg/kg/day | NS birth weight | NS birth weight | ↓ BW 3-8 months impaired glucose tolerance 3 months glucose intolerance |
↓ BW NS glucose tolerance |
|
[61] | 10 μg/kg/day and 10 mg/kg/day |
16 to 21 weeks Both doses of BPA significantly impaired insulin secretion |
||||
[62] | 50ng, 50µg, or 50mg BPA/kg | ↓ ADP at 50 µg BPA/kg NS fat mass and body weight |
↑ ADP ♀ (50 ng and 50 mg of BPA/kg diet) ↓ the mean baseline glucose and insulin levels (50 mg of BPA/kg diet) ↑ fat mass and body weight ↓ serum leptin ↓ insulin and HOMA-IR (50 mg of BPA/kg diet) |
|||
[63] | 50 µg/kg/day | 20 weeks ↑ BW ↑ epididymal and perirenal fat pads ↑ food intake NS fasting glucose and glucose tolerance test ↑ insulin and leptin levels impaired glucose homeostasis ↑ food intake |
||||
[64] | 0.1 mg/L | NS BW NS food intake NS water intake |
NS BW ↓ glucose metabolism |
|||
[65] | 0.05mg/kg/day | ↑ glucose level IR |
||||
[66] | 2.5, 25, and 250µg/kg/day | NS BW NS plasma lipid profile (cholesterol, HDL, LDL, and TG) |
||||
[67] | 20 and 40 µg/kg/day |
↓ BW | ↓ BW ↑ foetal serum leptin ↑ insulin levels in both treated groups |
Increase (↑); decrease (↓) and non-significant relative to those in the control groups (NS). Empty cells mean the parameters were not examined in the studies.